Allarity Therapeutics Inc. (ALLR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Allarity Therapeutics Inc...

NASDAQ: ALLR · Real-Time Price · USD
1.72
-0.01 (-0.58%)
At close: Sep 04, 2025, 3:59 PM

Allarity Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
9K 37K 120K 106K
Gross Profit
-9K -37K -120K -106K
Operating Income
-27.24M -17.93M -34.46M -26.56M
Interest Income
533K 22K 30K n/a
Pretax Income
-24.9M -12.62M -17.58M -26.52M
Net Income
-24.52M -11.9M -16.06M -26.65M
Selling & General & Admin
11.44M 10.03M 9.96M 12.36M
Research & Development
6.1M 7.87M 6.93M 14.2M
Other Expenses
791K n/a n/a n/a
Operating Expenses
18.33M 17.89M 16.89M 26.56M
Interest Expense
-653K 498K 223K 499K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
27.24M 17.93M 16.89M 26.56M
Income Tax Expense
-381K -717K -1.52M 133K
Shares Outstanding (Basic)
1.58M 1.99M 11.34 7.57
Shares Outstanding (Diluted)
1.58M 1.99M 11.34 7.57
EPS (Basic)
-15.56 -0.01 -1.86M -3.52M
EPS (Diluted)
-15.56 -0.01 -1.86M -3.52M
EBITDA
-27.24M -12.08M -17.24M -25.91M
EBIT
-25.55M -12.12M -17.36M -26.02M
Depreciation & Amortization
-1.69M 37K 120K 106K